CBX3 and colonic neoplasm: To investigate the mechanism by which CBX3 promotes colon cancer, we deleted CBX3 in HCT116 with the CRISPR/Cas9 editing system and found that cell cycle progression was curbed in G1 phase and proliferation was inhibited.